Baylor Research Institute (BRI): Functional MR in Ischemic Cardiomyopathy

	A CHR Trial Investigation Outcomes of Exercise Training
	Altered CD8+ T Cell Compartment in SLE Patients
	A Systems Biology Approach for Pediatric and Adult Autoimmune Diseases
	Genome-Wide Profiling of Antigen-Specific Immunoreactivity in Multiple Sclerosis (A Pilot Project to ‘A Systems Biology Approach for Pediatric and Adult Autoimmune Diseases’; PI: Virginia Pascual, MD)
	A Systems Biology Approach to Islet Antigen Immunoreactivity Profiling in T1D
	Biology and Diagnosis of HNPCC
	Blood Transcriptional Biomarker Profiles for Category B Pathogens
	Center for Lupus Research
	Colon Cancer Prevention Program Project
	Development of Neonatal Oxygen Therapy Information System to Support Oximetry Targets in Newborn Intensive Care Units
	Diversification of cytotoxic effector cells via LPS-activated DCs
	Effect of S-adenosylmethionine on Blood Homocysteine
	Functional MR in Ischemic Cardiomyopathy
	Harnessing Human DC Subsets for Improved Mucosal Vaccines
	Supplement #1 to ‘Harnessing Human DC Subsets for Improved Mucosal Vaccines’
	Supplement #2 to ‘Harnessing Human DC Subsets for Improved Mucosal Vaccines’
	Supplement #3 to ‘Harnessing Human DC Subsets for Improved Mucosal Vaccines’
	Immunotherapeutic HPV Cancer Vaccines that Target Langerhans Cells
	Improving the Efficacy of Dendritic Cell Vaccines
	JC Virus and Tumor Formation in the Human Colon
	Monitoring Blood Genome Activity during Pregnancy
	Novel Dendritic Cell-Based HIV Vaccines
	Rural Hospital Collaborative for Excellence Using IT
	Towards an HCV Vaccine
	Transcriptional Signatures for Diagnosis of Different Spectra of Mycobacterium tuberculosis Infection and Characterization of the Immune Response during Latency or Active Disease
	Use of Microarrays to Understand Systemic Arthritis
	Vaccination with IL-15 DC to Generate Melanoma-Specific Protective Memory T Cells

Functional MR in Ischemic Cardiomyopathy

Grant Number: 5R01HL072430-03
PI: Paul A. Grayburn
ICD: National Heart, Lung, and Blood Institute
IRG: ZHL1
Project Start: September 20, 2002
Project End: December 31, 2007

Abstract:

Functional mitral regurgitation (MR) is a common complication of ischemic heart disease. Two large clinical trials confirmed an adverse effect of functional MR on survival after a heart attack. However, studies in heart failure are small and mainly limited to patients with nonischemic cardiomyopathy. Recent animal studies have challenged the traditional concept that functional MR is a consequence of mitral annular dilation, instead suggesting that functional MR is due to leaflet tethering by outward expansion of the left ventricular wall (i.e. LV remodeling). This has critical implications regarding the correct surgical approach to correcting functional MR. To date, no large prospective studies have examined the mechanism(s) of functional MR in ischemic cardiomyopathy, nor has the interaction between mechanism and prognosis been explored. This is a crucial knowledge gap because 1) 70% of heart failure cases are caused by ischemic heart disease, and 2) functional MR occurs in around 60% of patients with ischemic cardiomyopathy. This proposal aims to fill these gaps by defining the mechanism(s) of functional MR by transesophageal echocardiography in a large clinical trial of patients with ischemic cardiomyopathy.

The following specific aims will be addressed: Aim 1: To define the mechanism(s) of functional MR in ischemic cardiomyopathy; Aim 2: To define the effect of therapy on mechanism and severity of functional MR; Aim 3: To evaluate the effect of functional MR on prognosis is ischemic cardiomyopathy; Aim 4: To evaluate the effect of myocardial viability on functional MR and its response to treatment. We propose to accomplish these aims as a ancillary study to the Surgical Treatment of Ischemic Heart Failure (STICH) Trial. The STICH Trial will compare surgical revascularization versus medical therapy for treatment of heart failure in 2800 patients with ischemic cardiomyopathy, and therefore affords a unique opportunity to investigate the mechanism(s) of functional MR. Despite its known clinical utility of assessing the mechanism and severity of MR, TEE is not currently included in STICH.